Sandrine Claus

Company: YSOPIA Bio

Job title: Chief Scientific Officer


Christenssenella Minuta a Novel Live Biotherapy for Obesity and Metabolic Diseases 1:50 pm

• Preclinical proof of concept of novel selected C. minuta clinical candidate strain, Xla1, for the treatment of obesity and metabolic diseases • Topline data Phase1 clinical study assessing Xla1 in healthy and obese volunteers • C. minuta therapeutic potential beyond obesityRead more

day: Track A - Evening - Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.